Downregulation of PP2A–PR61β and PP2A–PR61γ seems to be a common event in AML cases, leading to the inactivation of PP2A, and consequently contributing to malignant cell proliferation (Table 1) (30). Here, PTPA is linked to acute myeloid leukemia.